|
12 Companies |
|
10 Products |
|
10 Products |
|
3 Mechanisms of Action |
|
0 Trials |
|
88 News |
|
| 12» |
- | Nebido (testosterone undecanoate depot injection) / Bayer
Trial completion date, Trial primary completion date: ALCeP: Androgen for Leydig Cell Proliferation (clinicaltrials.gov) - Sep 26, 2018
P2/3, N=56, Completed, Sponsor: University of Roma La Sapienza
Trial completion date: Oct 2014 --> Jun 2018 | Trial primary completion date: Aug 2013 --> Jun 2017
- | Growtropin-II (somatropin biosimilar) - Dong / A
Trial completion: A Clinical Study to Assess the Efficacy and Safety of DA-3002 (clinicaltrials.gov) - Jul 27, 2018
P3, N=58, Completed, Sponsor: Dong-A ST Co., Ltd.
Trial completion date: Oct 2014 --> Jun 2018 | Trial primary completion date: Aug 2013 --> Jun 2017 Active, not recruiting --> Completed
- |||| Growtropin-II (somatropin biosimilar) - Dong / A
Trial primary completion date: A Clinical Study to Assess the Efficacy and Safety of DA-3002 (clinicaltrials.gov) - Sep 20, 2017
P3, N=58, Active, not recruiting, Sponsor: Dong-A ST Co., Ltd.
Active, not recruiting --> Completed Trial primary completion date: Jun 2016 --> May 2018
- | Trial completion, Trial primary completion date: Risk of Diabetes in Young Turner Syndrome Patients (clinicaltrials.gov) - Aug 23, 2017
P=N/A, N=120, Completed, Sponsor: Children's Hospital Medical Center, Cincinnati
Trial primary completion date: Jun 2016 --> May 2018 Recruiting --> Completed | Trial primary completion date: Dec 2015 --> Jun 2017
- | Trial completion: The Effects of Hormones in Growth Hormone-Treated Girls With Turner Syndrome (clinicaltrials.gov) - Jun 30, 2017
P2, N=80, Completed, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting --> Completed | Trial primary completion date: Dec 2015 --> Jun 2017 No longer recruiting --> Completed
- | Trial completion, Enrollment change, Trial primary completion date: Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes (clinicaltrials.gov) - Mar 15, 2017
P=N/A, N=20, Completed, Sponsor: University of Colorado, Denver
No longer recruiting --> Completed Recruiting --> Completed | N=100 --> 20 | Trial primary completion date: Oct 2016 --> Jul 2016
- ||| Norditropin (somatropin) / Novo Nordisk
Trial completion, Enrollment change: Observational Prospective Study on Patients Treated With Norditropin® (clinicaltrials.gov) - Feb 6, 2017
P=N/A, N=21249, Completed, Sponsor: Novo Nordisk A/S
Recruiting --> Completed | N=100 --> 20 | Trial primary completion date: Oct 2016 --> Jul 2016 Enrolling by invitation --> Completed | N=17000 --> 21249
- Trial completion: GenTAC: National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (clinicaltrials.gov) - Dec 20, 2016
P=N/A, N=3706, Completed, Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Enrolling by invitation --> Completed | N=17000 --> 21249 Active, not recruiting --> Completed
- Trial completion, Enrollment change: Subcapsular Orchiectomy in Men With Klinefelter Syndrome (clinicaltrials.gov) - Oct 4, 2016
P=N/A, N=14, Completed, Sponsor: Odense University Hospital
Active, not recruiting --> Completed Recruiting --> Completed | N=20 --> 14
- Trial completion, Enrollment change, Trial primary completion date: Pregnancy Chances in Classic Galactosemia (clinicaltrials.gov) - Sep 13, 2016
P=N/A, N=85, Completed, Sponsor: Maastricht University Medical Center
Recruiting --> Completed | N=20 --> 14 Recruiting --> Completed | N=150 --> 85 | Trial primary completion date: Dec 2015 --> Sep 2016
- Trial primary completion date: Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes (clinicaltrials.gov) - Aug 22, 2016
P=N/A, N=100, Recruiting, Sponsor: University of Colorado, Denver
Recruiting --> Completed | N=150 --> 85 | Trial primary completion date: Dec 2015 --> Sep 2016 Trial primary completion date: Jun 2016 --> Oct 2016
- Trial primary completion date: Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes (clinicaltrials.gov) - Jun 2, 2016
P=N/A, N=100, Recruiting, Sponsor: University of Colorado, Denver
Trial primary completion date: Jun 2016 --> Oct 2016 Trial primary completion date: Mar 2016 --> Jun 2016
- Trial completion, Enrollment change, Trial primary completion date: Aortopathy in Persons With Bicuspid Aortic Valve, Turner and Marfan Syndrome (clinicaltrials.gov) - May 25, 2016
P=N/A, N=5, Completed, Sponsor: University of Aarhus
Trial primary completion date: Mar 2016 --> Jun 2016 Recruiting --> Completed | N=60 --> 5 | Trial primary completion date: Oct 2016 --> Oct 2015
- Trial completion, Enrollment change: X-chromosome Inactivation, Epigenetics and the Transcriptome (clinicaltrials.gov) - May 25, 2016
P=N/A, N=110, Completed, Sponsor: University of Aarhus
Recruiting --> Completed | N=60 --> 5 | Trial primary completion date: Oct 2016 --> Oct 2015 Active, not recruiting --> Completed | N=395 --> 110
- Trial completion, Trial primary completion date: Genetic Etiology in Premature Ovarian Insufficiency (clinicaltrials.gov) - Apr 18, 2016
P=N/A, N=100, Completed, Sponsor: BEGUM AYDOGAN
Active, not recruiting --> Completed | N=395 --> 110 Recruiting --> Completed | Trial primary completion date: Nov 2015 --> Apr 2016
- Trial primary completion date: Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes (clinicaltrials.gov) - Jan 18, 2016
P=N/A, N=100, Recruiting, Sponsor: University of Colorado, Denver
Recruiting --> Completed | Trial primary completion date: Nov 2015 --> Apr 2016 Trial primary completion date: Nov 2015 --> Mar 2016
- ||| somatropin / Generic mfg.
Trial completion: GeNeSIS: Observational Study of Somatropin Treatment in Children (clinicaltrials.gov) - Oct 27, 2015
P=N/A, N=22929, Completed, Sponsor: Eli Lilly and Company
Trial primary completion date: Nov 2015 --> Mar 2016 Active, not recruiting --> Completed
- Trial primary completion date: Risk of Diabetes in Young Turner Syndrome Patients (clinicaltrials.gov) - Sep 28, 2015
P=N/A, N=120, Recruiting, Sponsor: Children's Hospital Medical Center, Cincinnati
Active, not recruiting --> Completed Trial primary completion date: Sep 2015 --> Dec 2015
- |||| somatropin / Generic mfg.
Trial completion, Enrollment change: Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome (clinicaltrials.gov) - Sep 26, 2015
P4, N=69, Completed, Sponsor: Eli Lilly and Company
Trial primary completion date: Sep 2015 --> Dec 2015 Recruiting --> Completed | N=88 --> 69
- Enrollment change, Trial termination, Trial primary completion date: Clinical Performance of the MaterniT21 PLUS LDT in Multiple Gestation Pregnancies (clinicaltrials.gov) - Sep 17, 2015
P=N/A, N=50, Terminated, Sponsor: Sequenom, Inc.
Recruiting --> Completed | N=88 --> 69 N=1000 --> 50 | Recruiting --> Terminated | Trial primary completion date: Feb 2015 --> Sep 2015; Slow enrollment of eligible subjects
- Trial primary completion date: Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes (clinicaltrials.gov) - Aug 22, 2015
P=N/A, N=100, Recruiting, Sponsor: University of Colorado, Denver
N=1000 --> 50 | Recruiting --> Terminated | Trial primary completion date: Feb 2015 --> Sep 2015; Slow enrollment of eligible subjects Trial primary completion date: Jul 2015 --> Nov 2015
- Norditropin (somatropin) / Novo Nordisk
Trial completion: Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome (clinicaltrials.gov) - Jul 6, 2015
P=N/A, N=2016, Completed, Sponsor: Novo Nordisk A/S
Trial primary completion date: Jul 2015 --> Nov 2015 Active, not recruiting --> Completed
- || Enrollment closed, Trial primary completion date: X-chromosome Inactivation, Epigenetics and the Transcriptome (clinicaltrials.gov) - Jun 29, 2015
P=N/A, N=395, Active, not recruiting, Sponsor: University of Aarhus
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2015 --> Oct 2015
- Trial primary completion date: Genetic Etiology in Premature Ovarian Insufficiency (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=100, Recruiting, Sponsor: BEGUM AYDOGAN
Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2015 --> Oct 2015 Trial primary completion date: Jan 2015 --> Nov 2015
- ||| Trial completion, Enrollment change: Life Quality and Health in Patients With Klinefelter Syndrome (clinicaltrials.gov) - Jun 3, 2015
P=N/A, N=452, Completed, Sponsor: University of Aarhus
Trial primary completion date: Jan 2015 --> Nov 2015 Enrolling by invitation --> Completed | N=1350 --> 452
- ||| Trial completion, Enrollment change: Neuropsychologic, Neuroradiologic, Endocrinologic, and Genetic Aspects of Klinefelter Syndrome (clinicaltrials.gov) - Jun 3, 2015
P=N/A, N=146, Completed, Sponsor: University of Aarhus
Enrolling by invitation --> Completed | N=1350 --> 452 Active, not recruiting --> Completed | N=450 --> 146
- Enrollment open: Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes (clinicaltrials.gov) - May 28, 2015
P=N/A, N=100, Recruiting, Sponsor: University of Colorado, Denver
Active, not recruiting --> Completed | N=450 --> 146 Not yet recruiting --> Recruiting
- Norditropin (somatropin) / Novo Nordisk
Enrollment closed: Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome (clinicaltrials.gov) - Apr 15, 2015
P=N/A, N=2000, Active, not recruiting, Sponsor: Novo Nordisk A/S
Not yet recruiting --> Recruiting Enrolling by invitation --> Active, not recruiting
- || Trial primary completion date: Aortopathy in Persons With Bicuspid Aortic Valve, Turner and Marfan Syndrome (clinicaltrials.gov) - Dec 7, 2014
P=N/A, N=60, Recruiting, Sponsor: University of Aarhus
Enrolling by invitation --> Active, not recruiting Trial primary completion date: Oct 2014 --> Oct 2016
- Trial completion: Dry Eye in Women With Turner Syndrome and Women With Premature Ovarian Failure (clinicaltrials.gov) - Nov 17, 2014
P=N/A, N=72, Completed, Sponsor: National Eye Institute (NEI)
Trial primary completion date: Oct 2014 --> Oct 2016 Recruiting --> Completed
- | Nebido (testosterone undecanoate depot injection) / Bayer
Trial completion, Enrollment change: ALCeP: Androgen for Leydig Cell Proliferation (clinicaltrials.gov) - Oct 28, 2014
P2/3, N=56, Completed, Sponsor: University of Roma La Sapienza
Recruiting --> Completed Recruiting --> Completed | N=20 --> 56
- ||| Clinical: Clinical Performance of the MaterniT21 PLUS LDT in Multiple Gestation Pregnancies (clinicaltrials.gov) - Aug 27, 2014
P=N/A, N=1000, Recruiting, Sponsor: Sequenom, Inc.
- ||| Zomacton (somatropin) / Ferring
Enrollment open, Adherence: ZOMAXEPT: Evaluation of the Adherence and the Patient Acceptability of Zomacton® Treatment With the Zomajet® Vision X Device (clinicaltrials.gov) - Jul 17, 2014
P=N/A, N=90, Recruiting, Sponsor: Ferring Pharmaceuticals
Recruiting --> Completed | N=20 --> 56 Not yet recruiting --> Recruiting
- Trial completion: Turner Syndrome: Genotype and Phenotype (clinicaltrials.gov) - Jul 12, 2014
P=N/A, N=1017, Completed, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Trial termination: DHEAFert: Study of Oral Dehydroepiandrosterone(DHEA) to Treat Previously Unexplained Infertility (clinicaltrials.gov) - Jul 1, 2014
P2/3, N=35, Terminated, Sponsor: Center for Human Reproduction
Active, not recruiting --> Completed Recruiting --> Terminated; Failure to recruit designed nuimebrt of subjects
- Enrollment change, Trial termination: DHEAFert: Study of Oral Dehydroepiandrosterone(DHEA) to Treat Previously Unexplained Infertility (clinicaltrials.gov) - Jul 1, 2014
P2/3, N=35, Terminated, Sponsor: Center for Human Reproduction
Recruiting --> Terminated; Failure to recruit designed nuimebrt of subjects N=220 --> 35 | Recruiting --> Terminated; Failure to recruit designed nuimebrt of subjects
- Clinical: Risk of Diabetes in Young Turner Syndrome Patients (clinicaltrials.gov) - Jun 12, 2014
P=N/A, N=120, Recruiting, Sponsor: Children's Hospital Medical Center, Cincinnati
- Trial primary completion date: Klinefelter Fertility Preservation (clinicaltrials.gov) - May 13, 2014
P=N/A, N=15, Completed, Sponsor: Children's Hospital Boston
N=220 --> 35 | Recruiting --> Terminated; Failure to recruit designed nuimebrt of subjects Trial primary completion date: Oct 2013 --> Apr 2014
- Enrollment change: Klinefelter Fertility Preservation (clinicaltrials.gov) - May 13, 2014
P=N/A, N=15, Completed, Sponsor: Children's Hospital Boston
Trial primary completion date: Oct 2013 --> Apr 2014 N=20 --> 15
- Trial completion: Klinefelter Fertility Preservation (clinicaltrials.gov) - May 13, 2014
P=N/A, N=15, Completed, Sponsor: Children's Hospital Boston
N=20 --> 15 Recruiting --> Completed
- Trial primary completion date: Sex Differences in Early Brain Development; Brain Development in Turner Syndrome (clinicaltrials.gov) - Apr 30, 2014
P=N/A, N=295, Completed, Sponsor: University of North Carolina, Chapel Hill
Recruiting --> Completed Trial primary completion date: May 2013 --> May 2014
- Trial completion date: Sex Differences in Early Brain Development; Brain Development in Turner Syndrome (clinicaltrials.gov) - Apr 30, 2014
P=N/A, N=295, Completed, Sponsor: University of North Carolina, Chapel Hill
Trial primary completion date: May 2013 --> May 2014 Trial completion date: May 2013 --> May 2014
- Trial completion: Sex Differences in Early Brain Development; Brain Development in Turner Syndrome (clinicaltrials.gov) - Apr 30, 2014
P=N/A, N=295, Completed, Sponsor: University of North Carolina, Chapel Hill
Trial completion date: May 2013 --> May 2014 Active, not recruiting --> Completed
- || Zomacton (somatropin) / Ferring
Trial initiation date, Adherence: ZOMAXEPT: Evaluation of the Adherence and the Patient Acceptability of Zomacton® Treatment With the Zomajet® Vision X Device (clinicaltrials.gov) - Mar 23, 2014
P=N/A, N=90, Not yet recruiting, Sponsor: Ferring Pharmaceuticals
Active, not recruiting --> Completed Initiation date: Mar 2014 --> Jun 2014
- Enrollment open: Genetic Etiology in Premature Ovarian Insufficiency (clinicaltrials.gov) - Mar 17, 2014
P=N/A, N=100, Recruiting, Sponsor: BEGUM AYDOGAN
Initiation date: Mar 2014 --> Jun 2014 Not yet recruiting --> Recruiting
- | Trial completion: Oxandrolone Compared With a Placebo on Growth Rate in Girls With Growth Hormone-Treated Turner's Syndrome (clinicaltrials.gov) - Feb 19, 2014
P2, N=80, Completed, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Not yet recruiting --> Recruiting No longer recruiting --> Completed
- || somatropin / Generic mfg.
Enrollment closed: GeNeSIS: Observational Study of Somatropin Treatment in Children (clinicaltrials.gov) - Feb 16, 2014
P=N/A, N=23500, Active, not recruiting, Sponsor: Eli Lilly and Company
No longer recruiting --> Completed Enrolling by invitation --> Active, not recruiting
- ||| Zorbtive (somatropin) / EMD Serono
Biomarker, Trial completion: PREDICT LT FUP: Long Term Follow up Study of Predictive Markers in GHD and TS Children (clinicaltrials.gov) - Feb 16, 2014
P=N/A, N=182, Completed, Sponsor: Merck KGaA
Enrolling by invitation --> Active, not recruiting Active, not recruiting --> Completed
- ||| Zomacton (somatropin) / Ferring
Adherence: ZOMAXEPT: Evaluation of the Adherence and the Patient Acceptability of Zomacton® Treatment With the Zomajet® Vision X Device (clinicaltrials.gov) - Dec 19, 2013
P=N/A, N=90, Not yet recruiting, Sponsor: Ferring Pharmaceuticals
- | Vivelle (estradiol transdermal system) / Sanofi, Hisamitsu, Novartis, Estreva oral (estradiol oral) / EMD Serono, Estrace (estradiol) / AbbVie
Trial completion: Estrogen Dosing in Turner Syndrome: Pharmacology and Metabolism (clinicaltrials.gov) - Dec 18, 2013
P4, N=41, Completed, Sponsor: Nemours Children's Clinic
Active, not recruiting --> Completed Active, not recruiting --> Completed